Aurobindo Pharma Ltd.

AUROPHARMA Share PricePharmaceuticals & Drugs

₹1,223.1

14.2 (1.2%)

As on December 4, 2025

Exchange Scrips: BSE524804NSEAUROPHARMAISININE406A01037

Market Cap ₹ 71,064 Cr

P/E Ratio 20.38

Dividend Yield N/A

Performance

Market performance

Open1,215.4

High1,226.8

Volumes7,40,597

Prev1,223.1

Low1,209.1

As on2025-12-04

Historical performance

1 Year High1,356.2

3 Year High1,592

5 Year High1,592

1 Year Low1,010

3 Year Low397.2

5 Year Low397.2

Fundamentals

Company Valuation

Market Cap (₹Cr)

71,064

Face Value (₹)

P/E Ratio

20.38

Dividend Yield

N/A

Investment Returns

1 Year

-2.9%

3 Years

160.2%

5 Years

35.8%

10 Years

51.6%

Technicals

Indicators	Value	Signal
5-DMA	1,218.02	Bullish
10-DMA	1,216.12	Bullish
20-DMA	1,207.2	Bullish
50-DMA	1,146.99	Bullish
100-DMA	1,117.32	Bullish
200-DMA	1,134.71	Bullish

Shareholding Pattern

Field	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Promoters	14	14	14	14	14
Foreign Investors	1	1	1	1	1
Domestic Investors	13	13	13	13	13
Public Investors	247648	272194	269309	257948	248474
Government	---	1	1	1	1

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 20.38.
3Y Stock Price CAGR of the stock is 38.0.
The stock has a beta of 1.1.
In the last financial year, the company had an EBITDA of ₹72046 Million.
The company generated revenue of ₹317237 Million in the previous financial year.

Aurobindo Pharma Ltd.

1223.114.2 (1.2%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 983476.1

No. of Shares: 804 (Approx)

Performance:-1.7%

P/L: ₹-16523.9

Top Gainers